NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: GOVERNMENT OWNED INVENTION AVAILABLE FOR LICENSE: CHIMERIC VLP VACCINES TO PREVENT HTLV-1 INFECTION

WASHINGTON, July 2 -- National Institutes of Health has issued a notice called: Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection.

The notice was published in the Federal Register on July 2 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.

Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for Chimeric VLP Vaccines to Prevent HTLV-1 Infection.

For more information, contact Inquiries related to this license opportunity should be directed to: Diptadip Dattaroy, Ph.D, Technology Transfer Manager, NCI, Technology Transfer Center, Email: [e-mail] Phone: [phone].

The full...